Based in Poland, Bioceltix is a startup.
Bioceltix is a biotechnology company developing innovative veterinary biological drugs based on allogenic mesenchymal stem cells (MSC) to treat inflammatory and autoimmune diseases in companion animals such as dogs and horses.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.